Public Profile

Techno Drugs Ltd.

Techno Drugs Ltd., a prominent player in the pharmaceutical industry, is headquartered in Bangladesh (BD) and operates extensively across South Asia. Founded in 2001, the company has established itself as a leader in the development and manufacturing of high-quality generic medicines, catering to a diverse range of therapeutic areas. With a commitment to innovation, Techno Drugs Ltd. offers a unique portfolio of products, including tablets, capsules, and injectables, all designed to meet stringent quality standards. The company’s state-of-the-art manufacturing facilities and adherence to international regulations have positioned it as a trusted supplier in both local and global markets. Recognised for its contributions to healthcare, Techno Drugs Ltd. continues to expand its reach, aiming to improve patient outcomes through accessible and affordable medication. Its dedication to research and development underscores its status as a key player in the pharmaceutical landscape.

DitchCarbon Score

How does Techno Drugs Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Techno Drugs Ltd.'s score of 20 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.

6%

Let us know if this data was useful to you

Techno Drugs Ltd.'s reported carbon emissions

Techno Drugs Ltd., headquartered in BD, currently does not have available carbon emissions data for recent years, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of concrete data, it is essential for Techno Drugs Ltd. to establish clear climate commitments and reduction strategies to align with industry standards and expectations for sustainability.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Techno Drugs Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Techno Drugs Ltd. is in BD, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Techno Drugs Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Renata PLC

BD
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Incepta Hygiene & Hospicare Ltd.

BD
Wearing apparel; furs (18)
Updated 5 days ago

Opso Saline Limited

BD
Chemicals nec
Updated 5 days ago

Nipro JMI Co. Ltd

BD
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago
DitchCarbon Score

JMI Hospital Requisite Manufacturing Limited

BD
Health and social work services (85)
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers